$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Indivior Pharmaceuticals, Inc. (NASDAQ: INDV)
Monteverde & Associates PC announced it is investigating Indivior Pharmaceuticals regarding its proposed merger with Supernus Pharmaceuticals. The firm specifically questions if the deal is fair, noting that Indivior shareholders are expected to own approximately 56.5% of the combined company.
Key figures
- Projected ownership percentage
- 56.5%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.